Status:
COMPLETED
Seroma Reduction After Mastectomy
Lead Sponsor:
Zuyderland Medisch Centrum
Conditions:
Seroma
Aspiration
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Rationale: Seroma formation and its sequelae form the mainstay of complications in breast cancer surgery. Seroma has an incidence of 3% to 85%. Complications vary from delayed wound healing, infection...
Detailed Description
1. INTRODUCTION AND RATIONALE Seroma formation is a common side effect after surgery for breast cancer, with an incidence of 3% to 85%. Seroma is a collection of serous fluid that contains blood p...
Eligibility Criteria
Inclusion
- Older than 18 years
- Female sex
- Indication for mastectomy or modified radical mastectomy
Exclusion
- Patients undergoing breast conserving therapy
- Patients undergoing direct breast reconstruction
- Unable to comprehend implications and extent of study and sign for informed consent
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT03305757
Start Date
June 1 2014
End Date
August 31 2019
Last Update
December 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuyderland Medisch Centrum
Sittard, Limburg, Netherlands, 6162 BG